Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...

Cell and gene therapies for degenerative eye diseases are still a long way off, but they have the potential to make a transformative difference to people’s lives. Vision impairment and loss ...

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...

If your plant is sporting crispy, dark or brown tips on the leaves, it’s more than just a cosmetic issue — it’s a signal that your plant care routine may need adjusting. There are several potential ...

The drug significantly reduced ER visits and hospital days in children MONDAY, April 21, 2025 (HealthDay News) -- An oral chemotherapy drug can safely and effectively manage sickle cell disease in ...

Stem cell therapies are a safe and effective way of treating Parkinson’s disease, according to results of two independent clinical trials. The two papers, published in the journal Nature, investigated ...

These cell lines and future research can help us uncover those mechanisms, and that could lead to new therapies for human diseases.” According to the study published by WSU, “A cell line is a ...

An all-encompassing guide to understanding Alzheimer's disease.